Skip to main content

Advertisement

Log in

Cytomegalovirus reactivation with bendamustine in patients with low-grade B-cell lymphoma

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Boeckh M, Nichols WG, Papanicolaou G et al (2003) Cytomegalovirus in hematopoietic stem cell transplant recipients: current status, known challenges, and future strategies. Biol Blood Marrow Transplant 9:543–558

    Article  PubMed  Google Scholar 

  2. Eid AJ, Razonable RR (2010) New developments in the management of cytomegalovirus infection after solid organ transplantation. Drugs 70:965–981

    Article  CAS  PubMed  Google Scholar 

  3. Torres HA, Kontoyiannis DP, Aguilera EA et al (2006) Cytomegalovirus infection in patients with lymphoma: an important cause of morbidity and mortality. Clin Lymphoma Myeloma 6:393–398

    Article  PubMed  Google Scholar 

  4. Matthew Rong Jie T, Soon Thye L et al (2014) Cytomegalovirus infection and end-organ disease in Asian patients with lymphoma receiving chemotherapy. Leuk Lymphoma 55(1):182–187

    Article  Google Scholar 

  5. Mitsumori T, Sueki Y et al (2014) Development of cytomegalovirus antigenemia in 3 patients with B cell lymphoma treated with bendamustine monotherapy. Rinsho Ketsueki 55(2):239–243

    PubMed  Google Scholar 

  6. Rummel MJ, Al-Batran SE, Kim SZ et al (2005) Bendamustine plus rituximab is effective and has a favorable toxicity profile in the treatment of mantle cell and low-grade non-Hodgkin’s lymphoma. J Clin Oncol 2:3383–3389

    Article  Google Scholar 

  7. Kahl BS, Bartlett NL, Leonard JP et al (2010) Bendamustine is effective therapy in patients with rituximab-refractory, indolent B-cell non- Hodgkin lymphoma: results from a Multicenter Study. Cancer 116:106–114

    CAS  PubMed Central  PubMed  Google Scholar 

  8. Lim SH, Pathapati S, Langevin J, Hoot A (2012) Severe CMV reactivation and gastritis during treatment of follicular lymphoma with bendamustine. Ann Hematol 91:643–644

    Article  PubMed  Google Scholar 

  9. Hosoda T, Yokoyama A et al (2013) Bendamustine can severely impair T-cell immunity against cytomegalovirus. Leuk Lymphoma 54:1327–1328

    Article  CAS  PubMed  Google Scholar 

  10. Takeda N et al (2001) Studies of Anti-Cytomegalovirus IgG antibody positive rate and cytomegalovirus mononucleosis in adults. Kansensho 75:775–779

    Article  CAS  Google Scholar 

Download references

Conflict of interest

The authors have no financial support or relationships that may pose conflicts of interest to declare.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tomonori Nakazato.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hasegawa, T., Aisa, Y., Shimazaki, K. et al. Cytomegalovirus reactivation with bendamustine in patients with low-grade B-cell lymphoma. Ann Hematol 94, 515–517 (2015). https://doi.org/10.1007/s00277-014-2182-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-014-2182-1

Keywords

Navigation